Totals
- Total revenue
- $615,134
- Total expenses
- $651,279
- Contributions and grants received
- $600,911
- Grants paid
- $331,876
- Program service revenue
- $0
- Investment income
- $39,278
- Other revenue
- -$25,055
- Total assets, end of year
- $1,686,816
- Total liabilities, end of year
- $109,127
- Net assets or fund balances, end of year
- $1,577,689
- Program services expenses (Part IX)
- $453,128
- Management and general expenses
- $78,041
- Fundraising expenses
- $120,110
- Program service expenses (Part III)
- $453,128
Program services were 69.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$55,104
-
1e · Government grants (contributions)
$105,764
-
1f · All other contributions, gifts and grants
$440,043
-
3 · Investment income
total $39,278 · excluded $39,278
-
8a · Fundraising events: gross income
$9,225
-
8a · Fundraising events: contributions included on line 1c
$55,104
-
8b · Fundraising events: direct expenses
$34,280
-
8c · Net income from fundraising events
total -$25,055
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $287,476 · program services $287,476
-
3 · Grants to foreign organizations and individuals
total $44,400 · program services $44,400
-
5 · Compensation of officers, directors and key employees
total $91,000 · program services $45,500 · fundraising $45,500
-
7 · Other salaries and wages
total $72,683 · program services $59,584 · management and general $13,095 · fundraising $4
-
9 · Other employee benefits
total $7,468 · program services $4,795 · management and general $597 · fundraising $2,076
-
10 · Payroll taxes
total $12,463 · program services $8,001 · management and general $997 · fundraising $3,465
-
11c · Fees: accounting
total $27,920 · management and general $27,920
-
11e · Fees: professional fundraising services
total $43,507 · fundraising $43,507
-
11g · Fees: other
total $7,775 · management and general $3,775 · fundraising $4,000
-
12 · Advertising and promotion
total $953 · fundraising $953
-
13 · Office expenses
total $813 · management and general $453 · fundraising $360
-
14 · Information technology
total $8,049 · management and general $2,746 · fundraising $5,303
-
16 · Occupancy
total $19,429 · management and general $19,429
-
17 · Travel
total $3,979 · program services $3,072 · management and general $431 · fundraising $476
-
22 · Depreciation, depletion and amortization
total $1,979 · management and general $1,979
-
23 · Insurance
total $6,405 · management and general $6,405
-
24a · Other expenses: DUES AND FEES
total $6,495 · program services $300 · fundraising $6,195
-
24b · Other expenses: BANK AND SERVICE CHARGES
total $5,514 · management and general $214 · fundraising $5,300
-
24c · Other expenses: DIRECT FUNDRAISING EXP
total $2,971 · fundraising $2,971
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $613,695 · end of year $496,909
-
2 · Savings and temporary cash investments
beginning of year $1,002,545 · end of year $1,069,673
-
3 · Pledges and grants receivable
beginning of year $7,642 · end of year $5,665
-
9 · Prepaid expenses and deferred charges
beginning of year $5,818 · end of year $5,692
-
10a · Land, buildings and equipment: cost or other basis
$5,938
-
10b · Land, buildings and equipment: accumulated depreciation
$1,979
-
10c · Land, buildings and equipment, net
beginning of year $5,938 · end of year $3,959
-
15 · Other assets
beginning of year $119,869 · end of year $104,918
-
17 · Accounts payable and accrued expenses
beginning of year $23,272 · end of year $5,677
-
25 · Other liabilities
beginning of year $118,401 · end of year $103,450
-
27 · Net assets without donor restrictions
beginning of year $250,033 · end of year $527,793
-
28 · Net assets with donor restrictions
beginning of year $1,363,801 · end of year $1,049,896
Mission and programs · 2025
Mission
SKC IMPACTS CHILDREN THROUGH THE INITIATION OF CLINICAL RESEARCH TRIALS OF INVESTIGATIVE TREATMENT STRATEGIES. OUR VISION IS TO CONTINUE EXPANDING THE ARMAMENTARIUM OF EFFECTIVE AND LESS TOXIC TREARTMENT STRATEGIES FOR PEDIATRIC ONCOLOGISTCS TO UTILIZE, UNTIL LONG-TERM SURVIVAL IS A REALITY FORVALL CHILDREN WITH HIGH-RISK SOLID TUMORS AND BRAIN TUMORS. TO ACCOMPLISH OUR MISSION, SKC FUNDS AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS THROUGH COLLABORATIVE PARTNERSHIPS WITH THE RESEARCH COMMUNITY AND RELATED NONPROFIT STAKEHOLDERS.
Activities or mission (Part I)
SOLVING KIDS' CANCER FINDS, FUNDS, AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS.
-
SKC LEADERSHIP AND SCIENTIFIC ADVISORS SURVEY, DISCUSS, AND PRIORITIZE THE AREAS OF GREATEST UNMET NEEDS WITHIN THE PEDIATRIC CANCER RESEARCH LANDSCAPE AND DEVELOP SPECIFIC PROGRAMS TO ADDRESS THEM. (1) SKC CONCEIVED AND ORGANIZED THE 2025 CARE FOR RARE GLOBAL STRATEGY FORUM, INVITING THE WORLD'S TOP EXPERTS IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) AND ATYPICAL TERATOID RHABDOID TUMOR (ATRT), TWO RARE AND AGGRESSIVE BRAIN TUMORS THAT AFFECT VERY YOUNG CHILDREN. THE OBJECTIVES OF THE MEETING WERE TO FACILITATE THE EXCHANGE OF INFORMATION AROUND EXISTING RESEARCH PROJECTS AND BUILD COLLABORATIONS ACROSS CONTINENTS. (2) SKC ISSUED A CALL FOR PROPOSALS AS A RESULT OF THE CARE FOR RARE STRATEGY FORUM AND AWARDED 600,000 IN COLLABORATION WITH PARTNER CHARITIES TO FUND THREE PROMISING PRE-CLINICAL PROJECTS TO ADVANCE TREATMENT OPTIONS FOR ETMR AND ATRT TUMOR TYPES. (3) SKC HAS ADVISORY ROLES ON NATIONAL AND INTERNATIONAL CLINICAL TRIALS CONSORTIA, REGULATORY BODIES, MULTI STAKEHOLDER PLATFORM FOR PEDIATRIC CANCER DRUG DEVELOPMENT, PHARMACEUTICAL COMPANIES, AND BUILDS COLLABORATIONS WITH OTHER NONPROFITS TO ADVOCATE FOR AND FUND RESEARCH. SKC REVIEWS PROPOSALS FOR THE NCI FUNDED CHILDREN'S ONCOLOGY GROUP AND THE DEPARTMENT OF DEFENSE RARE CANCER RESEARCH PROGRAMMATIC PANEL. SKC WAS INVITED TO SERVE ON PANELS AND PRESENT AT SEVEN SCIENTIFIC MEETINGS IN FIVE COUNTRIES. SKC CO-AUTHORED SEVERAL PEER-REVIEWED JOURNAL ARTICLES AND PEDIATRIC ONCOLOGY TEXTBOOK CHAPTERS. THESE ROLES GIVE SKC OPPORTUNITY TO INFLUENCE RESEARCH AGENDAS AND PRIORITIES.
Expenses $453,128 · Grants $331,876
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
KRISTI MCKAY
EXECUTIVE DI
- Total calculated
- $94,004
- From this org
- $90,612
- From related orgs
- $0
- Other
- $3,392
- Hours/week
- 40
-
MARK SAVOYE
CO-CHAIR
- Total calculated
- $0
- Hours/week
- 2
-
CHANNING STAVE
CO-CHAIR
- Total calculated
- $0
- Hours/week
- 2
-
MICHELE ALEXANDER
CO-SECRETARY
- Total calculated
- $0
- Hours/week
- 2
-
CATHERINE MURCHIE
CO-SECRETARY
- Total calculated
- $0
- Hours/week
- 2
-
EYAL SOFFER
TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
HEARN JAY CHO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
LINDY GAD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
JOHN LONDON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
MICHAEL NIEDZIELSKI
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
CATHERINE LONDON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
DEBORAH HUGHES
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
CINDY CAMPBELL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
JAN PLANIT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
CANCER RESEARCH
-
$50,000
CANCER RESEARCH
-
$50,000
CANCER RESEARCH
-
CANCER RESEARCH
-
CANCER RESEARCH
-
$34,807
CANCER RESEARCH
-
VARIOUS ORGANIZATIONS
$7,455
CANCER RESEARCH
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501C3 · PROGRAM · NY
Provenance
- Return type
- form_990
- Tax year
- 2025
- IRS schema version
- 2025v4.0
- Source object
- 202632679349300833
The source document this was parsed from is served over the API, which is where bulk and document access live.